Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $116.9900 (0.81%) ($115.7900 - $117.0700) on Wed. Jul. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.93% (three month average) | RSI | 73 | Latest Price | $116.9900(0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(44%) SPLV(35%) VYM(32%) XLP(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.465% in a week (0% probabilities). VIXM(-20%) UUP(-10%) VXX(-2%) TLT(-2%) KWEB(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.465% (StdDev 0.93%) | Hourly BBV | 0.9 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $116.63(0.31%) | 10 Day Moving Average | $116.89(0.09%) | 20 Day Moving Average | $115.61(1.19%) | To recent high | -0.8% | To recent low | 6.3% | Market Cap | $206.403b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |